Veloxis Pharmaceuticals A/S at its Extraordinary General Meeting held on 17 February 2020, elected members of the Board of Directors: Masaya Etoh, Daisuke Matsuo, and Matthew Ryan Dumont. The elected board members replace all current members of the Board of Directors who have resigned from the Board of Directors as of 17 February 2020. Subsequently, the Board of Directors has constituted itself with Masaya Etoh as Chairman.